Infection with bluetongue virus (serotypes 1-24) (infection with BTV) and infection with epizootic haemorrhagic disease virus are vector-borne diseases, and they have a similar epidemiology. They are also both listed diseases, as defined in Article 4, point (18), of Regulation (EU) 2016/429, and they are subject to the disease prevention and control rules laid down in Article 9 of that Regulation. In addition, they are both listed as categories D and E diseases in the Annex to Commission Implementing Regulation (EU) 2018/1882 [Commission Implementing Regulation (EU) 2018/1882 of 3 December 2018 on the application of certain disease prevention and control rules to categories of listed diseases and establishing a list of species and groups of species posing a considerable risk for the spread of those listed diseases (OJ L 308, 4.12.2018, p. 21, ELI: http://data.europa.eu/eli/reg_impl/2018/1882/oj).] following a recent amendment made by Commission Implementing Regulation (EU) 2026/169 [Commission Implementing Regulation (EU) 2026/169 of 26 January 2026 amending the Annex to Implementing Regulation (EU) 2018/1882 concerning the categorisation of infection with bluetongue virus (serotypes 1-24) as a listed disease (OJ L, 2026/169, 27.1.2026, ELI: http://data.europa.eu/eli/reg_impl/2026/169/oj).] that has re-categorised infection with BTV as a category D+E disease. Implementing Regulation (EU) 2026/169 applies from 15 July 2026.
Recital 2, Regulation (EU) 2026/501
In forcesince 5 Mar 2026